Aristocort: Expert-Grade Topical Corticosteroid for Inflammation Relief
| Product dosage: 4mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $1.12 | $67.31 (0%) | 🛒 Add to cart |
| 90 | $1.05 | $100.96 $94.43 (6%) | 🛒 Add to cart |
| 120 | $1.00 | $134.61 $119.54 (11%) | 🛒 Add to cart |
| 180 | $0.95 | $201.92 $171.78 (15%) | 🛒 Add to cart |
| 270 | $0.93
Best per pill | $302.88 $250.14 (17%) | 🛒 Add to cart |
Synonyms | |||
Aristocort (triamcinolone acetonide) is a mid-potency corticosteroid indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. As a synthetic glucocorticoid, it functions by inducing phospholipase A2 inhibitory proteins, thereby controlling the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes. Its efficacy, established through decades of clinical use, makes it a cornerstone in dermatological therapy for managing a range of cutaneous conditions, offering targeted anti-inflammatory, antipruritic, and vasoconstrictive actions with a well-characterized safety profile when applied as directed.
Features
- Active ingredient: Triamcinolone acetonide
- Available formulations: Cream, ointment, lotion, and aerosol
- Potency classification: Group 4 mid-potency corticosteroid (US classification)
- Concentrations: 0.025%, 0.1%, and 0.5%
- Prescription status: Requires medical prescription
- Vehicle options: Hydrophilic base (cream), occlusive base (ointment), or non-greasy lotion for varied skin types and conditions
Benefits
- Rapid reduction of inflammation, erythema, and edema in affected dermatological areas
- Effective suppression of pruritus associated with allergic and inflammatory skin conditions
- Minimizes risk of systemic absorption compared to higher-potency corticosteroids when used appropriately
- Multiple formulation options allow for tailored treatment based on lesion type, location, and patient preference
- Established safety profile with extensive clinical documentation spanning decades of use
- Cost-effective therapeutic option within the corticosteroid class
Common use
Aristocort is commonly prescribed for the treatment of corticosteroid-responsive dermatoses including atopic dermatitis, contact dermatitis, nummular eczema, psoriasis (excluding widespread plaque psoriasis), lichen planus, and seborrheic dermatitis. It may also be used off-label for certain other inflammatory skin conditions under medical supervision. The selection of formulation (cream, ointment, or lotion) depends on the nature and location of the lesions, with ointments generally preferred for drier, lichenified areas and creams for moist or intertriginous areas.
Dosage and direction
Apply a thin film of Aristocort to the affected area 2-4 times daily, depending on the severity of the condition. The frequency of application may be reduced as clinical improvement occurs. For most dermatoses, application twice daily is sufficient. The total dosage should not exceed 50 grams per week for adults, as exceeding this may increase the risk of systemic absorption. For pediatric patients, the minimum amount necessary to achieve therapeutic effect should be used, with careful monitoring for hypothalamic-pituitary-adrenal (HPA) axis suppression. Occlusive dressings may be used for resistant lesions but only under medical supervision due to significantly increased percutaneous absorption.
Precautions
Aristocort should not be used on large surface areas, for prolonged periods, or with occlusive dressings without medical supervision due to increased risk of systemic absorption. Use with caution in patients with liver impairment, as reduced metabolism may increase systemic exposure. Avoid application to the face, groin, or axillae unless directed by a physician, as these areas demonstrate higher percutaneous absorption. Discontinue use if irritation develops. Patients should be advised that this medication is for external use only and should not be used in the eyes or on mucous membranes. Use during pregnancy only if clearly needed and potential benefits justify potential risks to the fetus.
Contraindications
Aristocort is contraindicated in patients with known hypersensitivity to triamcinolone acetonide or any component of the formulation. It should not be used for the treatment of rosacea, perioral dermatitis, acne vulgaris, or cutaneous infections including viral (herpes simplex, varicella), fungal, or bacterial infections unless appropriate antimicrobial therapy is instituted concurrently. Not recommended for use in children under 2 years of age due to increased risk of systemic absorption and potential effects on growth and development.
Possible side effect
The most common side effects include localized burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, and hypopigmentation. With prolonged use or application under occlusion, the following may occur: skin atrophy, striae, telangiectasia, miliaria, and secondary infection. Systemic absorption may lead to reversible HPA axis suppression, manifestations of Cushing’s syndrome, hyperglycemia, and glucosuria in some patients. These effects are more likely to occur with use of higher potency formulations, application to large surface areas, prolonged use, or use of occlusive dressings.
Drug interaction
No specific drug interactions have been documented with topical application of Aristocort. However, caution should be exercised when using other topical products concurrently, as this may increase the risk of local adverse effects or altered absorption. Systemic interactions are unlikely with appropriate topical use but could theoretically occur with significant systemic absorption, potentially altering the metabolism of other medications processed by the CYP3A4 enzyme system.
Missed dose
If a dose is missed, apply it as soon as remembered. However, if it is almost time for the next application, skip the missed dose and resume the regular dosing schedule. Do not apply a double dose to make up for a missed application. Consistent application is important for therapeutic efficacy, but occasional missed doses are unlikely to significantly impact overall treatment outcomes for most dermatological conditions.
Overdose
Topically applied Aristocort can be absorbed in sufficient amounts to produce systemic effects. Acute overdose is unlikely but may manifest as systemic corticosteroid effects including hypercorticism and adrenal suppression. There is no specific antidote for triamcinolone acetonide overdose. Treatment should be symptomatic and supportive. In cases of chronic overuse, the medication should be discontinued gradually rather than abruptly to allow recovery of adrenal function if suppression has occurred.
Storage
Store at controlled room temperature between 20°C to 25°C (68°F to 77°F). Do not freeze. Keep the tube tightly closed when not in use. Protect from excessive heat and direct light. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Proper storage ensures stability and efficacy of the medication throughout its shelf life.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Individual patient responses to Aristocort may vary. A healthcare professional should be consulted for diagnosis and treatment of medical conditions. The prescriber should be informed of all current medications and medical history before using this product. Use only as directed by a qualified healthcare provider.
Reviews
Clinical studies have demonstrated Aristocort to be effective in managing inflammatory dermatoses, with approximately 70-80% of patients showing significant improvement within 2-4 weeks of treatment. Dermatologists frequently report satisfactory patient outcomes, particularly noting its efficacy in reducing pruritus and inflammation with a favorable side effect profile when used appropriately. Patient satisfaction surveys indicate high levels of effectiveness for designated conditions, though some users report concerns about potential side effects with prolonged use. The medication maintains a strong position in treatment algorithms due to its proven efficacy across multiple dermatological conditions and well-established safety data.